uk 68798 has been researched along with Tachycardia, Supraventricular in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Torp-Petersen, C | 1 |
| Khan, MH | 1 |
| Roukoz, H; Saliba, W | 1 |
| Atarashi, H; Hayakawa, H; Ino, T; Kobayashi, Y; Kuruma, A; Nomura, A; Saitoh, H | 1 |
| Pritchett, EL; Wilkinson, WE | 1 |
| Droszcz, W; Graff, O; Kawecka-Jaszcz, K; Kozlowski, JW; Krzeminska-Pakula, M; Kulakowski, P; Malolepszy, J; Ruzyllo, W; Swiatecka, G; Szechinski, J; Tendera, M; Wnuk-Wojnar, AM | 1 |
3 review(s) available for uk 68798 and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Dofetilide: a new drug to control cardiac arrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Phenethylamines; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Sulfonamides; Tachycardia, Supraventricular | 2003 |
Oral class III antiarrhythmics: what is new?
Topics: Amiodarone; Anti-Arrhythmia Agents; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides; Tachycardia, Supraventricular; Tachycardia, Ventricular; Treatment Outcome | 2004 |
Dofetilide: a new class III antiarrhythmic agent.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiologic Techniques, Cardiac; Heart Failure; Humans; Phenethylamines; Randomized Controlled Trials as Topic; Sulfonamides; Tachycardia, Supraventricular; Torsades de Pointes; Ventricular Function, Left | 2007 |
2 trial(s) available for uk 68798 and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Effect of dofetilide on survival in patients with supraventricular arrhythmias.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenethylamines; Potassium Channel Blockers; Proportional Hazards Models; Risk Factors; Safety; Sulfonamides; Survival Rate; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Treatment Outcome | 1999 |
Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Phenethylamines; Propafenone; Proportional Hazards Models; Sulfonamides; Survival Analysis; Tachycardia, Supraventricular; Treatment Outcome | 2001 |
1 other study(ies) available for uk 68798 and Tachycardia, Supraventricular
| Article | Year |
|---|---|
Clinical and electrophysiologic effects of dofetilide in patients with supraventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrophysiology; Female; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Phenethylamines; Sulfonamides; Tachycardia, Supraventricular | 1997 |